Pancreatic Cancer Research

ResearcherKagawa UniversityActive in the last 2 years

Mina Nagao

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0003-1241-2002; OpenAlex author ID A5104336704. Sources: OpenAlex.

Their work

Papers
8 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
11
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: none · 2024: 6 papers

Papers 8

  1. Predictive role of the prognostic nutritional index in patients with pancreatic ductal adenocarcinoma who underwent neoadjuvant chemoradiotherapy followed by c… Co-author DOI 10.1002/jhbp.1424↗
  2. Tumor location, clinicopathological features, and perioperative and prognostic outcomes in patients who underwent pancreatic resection following neoadjuvant ch… Co-author DOI 10.1016/j.pan.2024.02.007↗
  3. Relationships between postoperative recurrences and standardized uptake value on 18F-fluorodeoxyglucose-positron emission tomography in patients with resectabl… First author DOI 10.1016/j.pan.2024.08.010↗
  4. Serum Carbohydrate Antigen 19-9 and Metabolite Hypotaurine Are Predictive Markers for Early Recurrence of Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1097/mpa.0000000000002304↗
  5. Prognostic Significance of 18F-FDG PET/CT and Tumor Metabolic Changes in Patients With Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.21873/anticanres.17151↗
  6. Short- and Long-Term Outcomes of Neoadjuvant Chemoradiotherapy Followed by Pancreatoduodenectomy in Elderly Patients with Resectable and Borderline Resectable … Co-author DOI 10.3390/jcm13051216↗
  7. Tumor metabolic alterations after neoadjuvant chemoradiotherapy predict postoperative recurrence in patients with pancreatic cancer. Co-author DOI 10.1093/jjco/hyac074↗
  8. 18F-fluorodeoxyglucose positron emission tomography to indicate conversion surgery in patients with initially unresectable locally advanced pancreatic cancer. Co-author DOI 10.1093/jjco/hyy033↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hironobu Suto · 8 shared papers, 2018–2024 · strength 1.32
  2. Minoru Oshima · 8 shared papers, 2018–2024 · strength 1.32
  3. Keiichi Okano · 8 shared papers, 2018–2024 · strength 1.32
  4. Ayaka Shimomura · 3 shared papers, 2022–2024 · strength 0.47
  5. Shigeo Takahashi · 2 shared papers, 2024 · strength 0.37
  6. Toru Shibata · 2 shared papers, 2024 · strength 0.37
  7. Tsutomu Masaki · 3 shared papers, 2018–2024 · strength 0.37
  8. Yukiko Wada · 2 shared papers, 2022–2024 · strength 0.29
  9. Yasuyuki Suzuki · 2 shared papers, 2018–2022 · strength 0.19
  10. Takashi Norikane · 1 shared paper, 2024 · strength 0.18
  11. Akihito Tsuji · 1 shared paper, 2018 · strength 0.07

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.